Clinuvel
Clinuvel is an Australia-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of genetic and metabolic disorders.
Business Model:
Revenue: $36.1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Clinuvel Information
Geographic Data
Address: 15 Queen Street
City: Melbourne
State: victoria
Zip: 3000
Country: AU
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
3,485,110Website Global Rank
3,479Website Monthly Traffic
Twitter Followers
Description
Clinuvel is an Australia-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of genetic and metabolic disorders.
Contact Phone:
Contact Email:
Clinuvel went public on 2/23/2001 on the Australian Securities Exchange
Listed Exchange:
Australian Securities Exchange
IPO Date:
2/23/2001
Ticker Symbol:
CUV
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 7/2014 | Travere Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
